Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBM vs GSK✓SelectedUSD · GSKIBM vs GSK performance historyLatest closeAs of-4.71%11/17
Stock and ETF performance explorer

IBM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+135.5%
GSK return
+43.9%
Excess return
+91.6%
Maximum drawdown
-37.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.7%-2.3%-2.4%-4.4%
7D-5.5%-3.0%-2.5%-5.1%
30D+0.2%+0.4%-0.1%+0.2%
3M+1.7%-1.2%+2.9%+1.8%
6M+6.9%+0.9%+5.9%+6.9%
YTD-19.8%+4.0%-23.8%-20.3%
1Y-20.1%+7.3%-27.4%-20.9%
3Y+65.1%+57.1%+8.0%+54.8%
5Y+135.5%+43.0%+92.6%+115.2%
All+135.5%+43.9%+91.6%+115.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling